BOSTON - Daniel Jick has been named to the Board of Directors at Beth Israel Deaconess Medical Center, the governing body responsible for ensuring that BIDMC fulfills its mission and vision.
Jick was elected at BIDMC's Annual Meeting Sept. 27, which also voted to name 28 new members to BIDMC's boards of Trustees and Overseers.
Jick is founder and vice chairman of HighVista Strategies, LLC. Established in 2005, HighVista follows an investment strategy similar to that employed by the most successful college endowments.
Formerly, Jick was a managing director and regional manager of Goldman Sachs & Co., where he managed the Boston office for 11 years. He previously worked in London as the head of the European derivatives business and in Boston as a senior member of the institutional equities business. Jick joined Goldman Sachs in 1981 and became a managing director in 1996.
Jick is a trustee at Brandeis University, where he is co-chairman of the Investment Committee and a member of the Executive Committee. He is also chairman of the CareGroup/Combined Jewish Philanthropies Board of Managers, which functions as the Investment Committee of the Boards of Directors, responsible for oversight of all investments and compliance with CareGroup's formal investment policy. He is the incoming chairman of the Investment Committee of Jewish Federations of North America.
He received an MBA from Harvard University in 1981 and a BA from Brandeis University in 1979. He and his wife, Elizabeth, live with their three children in Chestnut Hill.
The members of the board of trustees serve as advisors to the board of directors and officers of BIDMC. Trustees serve on committees of the board of directors and identify and involve potential supporters and resources for programs and facilities of the medical center, among other responsibilities.
Frederick Wang of Boston was re-elected as Chairman of the Board of Trustees.
Newly elected trustees include: Karen Bressler, Michelle A. Dipp, MD, PhD, John W. Humphrey, and Ann B. Spence of Boston; Ellen S. Calmas and David Schechter of Chestnut Hill; Danielle F. Remis Hackel of Brookline; Scott L. Minick of Cambridge; and Howard B. Rubin of Weston.
Newly elected trustees emeritus, recognized for their outstanding contribution and support of the medical center, include: Alan L. LeBovidge of North Andover; William M. Marcus of Chestnut Hill; Gilda Slifka and Roberta S. Weiner of Boston; and David T. Ting of Southboro.
The members of the board of overseers act as good-will ambassadors within the communities served by the medical center. The overseers highlight the importance of BIDMC's mission to their local communities and strengthen the medical center's ability to advance its mission through philanthropy.
Sidney Queler of Needham was re-elected Chairman of the Board of Overseers.
Newly elected overseers include: Nicole Bartlett and Pamela Lesser of Wayland; Andrew Bendheim of Natick; Ashley Bernon of Wellesley; Christine Bunt of Lexington; Lorrayne Chu of West Newton; Keith Denham and Steven Garfinkel of Weston; Phillip Edmundson of Hingham; R. John Fletcher of Wellesley Hills; Jeff Hotchkiss of Manchester-by-the-Sea; Brian Knez, Kate Lubin and Kevin Washington of Boston; Rizwan Mallal and Ellen Offner of Newton; Bram Shapiro of Brookline; James Stuart of Dover; and Eric Turner of Waban.
Newly elected overseers emeritus recognized for their outstanding contribution and support of the medical center, include: Robert R. Beck of Alstead, NH; Kathryn R. Bloom, Stephen P. Kaufman and Rhonda S. Zinner of Boston; David P. Fialkow of Cambridge; William M. Karlyn, Lionel B. Spiro and Laura B. Trust of Brookline; Helaine A. Miller and Lizbeth L. Tarlow of Chestnut Hill; Peter M. Small of Concord; Robert A. Smith of Wellesley Hills; and Howard P. Tanger of Needham.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit